Yumei Wei

Department Of Otolaryngology Head And Neck Surgery
Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

CCL3+ Neutrophil Signature Predicts Response to Neoadjuvant Toripalimab plus Chemotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Phase II Trial.

CCL3+ Neutrophil Signature Predicts Response to Neoadjuvant Toripalimab plus Chemotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 27, 2025

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study.

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study.

Journal: Signal transduction and targeted therapy

Published: June 20, 2025

Hypopharyngeal Squamous Cell Carcinoma in Elderly Patients Aged ≥70 Years: Surgery and Postoperative Radiotherapy Improves Outcomes in Selected Patients.

Hypopharyngeal Squamous Cell Carcinoma in Elderly Patients Aged ≥70 Years: Surgery and Postoperative Radiotherapy Improves Outcomes in Selected Patients.

Journal: Cancer management and research

Published: April 29, 2025

Matched-pair analysis of the impact of low-dose postoperative radiotherapy on prognosis in patients with advanced hypopharyngeal squamous cell carcinoma without positive surgical margins and extracapsular extension.

Matched-pair analysis of the impact of low-dose postoperative radiotherapy on prognosis in patients with advanced hypopharyngeal squamous cell carcinoma without positive surgical margins and extracapsular extension.

Journal: Frontiers in oncology

Published: November 04, 2022

Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?

Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?

Journal: Radiation oncology (London, England)

Published: August 17, 2022

Significance of CD8+ T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma.

Significance of CD8+ T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma.

Journal: Aging

Published: May 26, 2021

The Efficacy of Low Postoperative Radiation Dose in Patients with Advanced Hypopharyngeal Cancer without High-Risk Factors.

The Efficacy of Low Postoperative Radiation Dose in Patients with Advanced Hypopharyngeal Cancer without High-Risk Factors.

Journal: Cancer management and research

Published: February 14, 2020

Coronin3 Promotes Nasopharyngeal Carcinoma Migration And Invasion By Induction Of Epithelial-To-Mesenchymal Transition.

Coronin3 Promotes Nasopharyngeal Carcinoma Migration And Invasion By Induction Of Epithelial-To-Mesenchymal Transition.

Journal: OncoTargets and therapy

Published: May 15, 2019

A case report about oligodendrogliomas of the fourth ventricle.

A case report about oligodendrogliomas of the fourth ventricle.

Journal: Medicine

Published: April 29, 2018

Effects of megavoltage computed tomographic scan methodology on setup verification and adaptive dose calculation in helical TomoTherapy.

Effects of megavoltage computed tomographic scan methodology on setup verification and adaptive dose calculation in helical TomoTherapy.

Journal: Radiation oncology (London, England)

Published: December 13, 2016

Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.

Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.

Journal: Oncotarget

Published: November 14, 2016

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma.

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma.

Journal: OncoTargets and therapy

Published: April 22, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026